Related references
Note: Only part of the references are listed.Calmodulin Binding to Death Receptor 5-mediated Death-Inducing Signaling Complex in Breast Cancer Cells
Romone M. Fancy et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Breast Cancer Statistics, 2015: Convergence of Incidence Rates Between Black and White Women
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
A Novel Imaging Biomarker Extracted from Fluorescence Microscopic Imaging of TRA-8/DR5 Oligomers Predicts TRA-8 Therapeutic Efficacy in Breast and Pancreatic Cancer Mouse Models
Harrison Kim et al.
MOLECULAR IMAGING AND BIOLOGY (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Characterization of the Interactions between Calmodulin and Death Receptor 5 in Triple-negative and Estrogen Receptor-positive Breast Cancer Cells AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY
Romone M. Fancy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Structural Insight for Roles of DR5 Death Domain Mutations on Oligomerization of DR5 Death Domain-FADD Complex in the Death-Inducing Signaling Complex Formation: A Computational Study
Hongyi Yang et al.
JOURNAL OF MOLECULAR MODELING (2016)
Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
Betsy A. Kohler et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
The ImageJ ecosystem: An open platform for biomedical image analysis
Johannes Schindelin et al.
MOLECULAR REPRODUCTION AND DEVELOPMENT (2015)
Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer
Kaiyu Yuan et al.
ONCOTARGET (2015)
Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
Betsy A. Kohler et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Combination therapy with anti-DR5 antibody and tamoxifen for triple negative breast cancer
Hyunki Kim et al.
CANCER BIOLOGY & THERAPY (2014)
US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
Nadia Howlader et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics
L. Y. Dimberg et al.
ONCOGENE (2013)
Effect of anti-DR5 and chemotherapy on basal-like breast cancer
Patsy G. Oliver et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Calmodulin Mediates Fas-induced FADD-independent Survival Signaling in Pancreatic Cancer Cells via Activation of Src-Extracellular Signal-regulated Kinase (ERK)
Kaiyu Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Mechanisms of Drug Sensitization to TRA-8, an Agonistic Death Receptor 5 Antibody, Involve Modulation of the Intrinsic Apoptotic Pathway in Human Breast Cancer Cells
Hope M. Amm et al.
MOLECULAR CANCER RESEARCH (2011)
Trifluoperazine regulation of calmodulin binding to Fas: A computational study
Di Pan et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2011)
Adjuvant therapy of triple negative breast cancer
Edith A. Perez et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
Ting-Chao Chou
CANCER RESEARCH (2010)
Calmodulin inhibition contributes to sensitize TRAIL-induced apoptosis in human lung cancer H1299 cells
Mi-kyung Hwang et al.
BIOCHEMISTRY AND CELL BIOLOGY (2009)
TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype
Monzur Rahman et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Identification of an antiapoptotic protein complex at death receptors
M. Sun et al.
CELL DEATH AND DIFFERENTIATION (2008)
The Hill equation: a review of its capabilities in pharmacological modelling
Sylvain Goutelle et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)
Tumor-derived mutations in the TRAIL receptor DR5 inhibit TRAIL signaling through the DR4 receptor by competing for ligand binding
Lianghua Bin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL
Klaus W. Wagner et al.
NATURE MEDICINE (2007)
Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis through downregulation of ERK and Akt in lung adenocarcinoma A549 cells
Cheung-Yun Jin et al.
CARCINOGENESIS (2007)
TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis
C. A. Dumitru et al.
ONCOGENE (2006)
Inducible resistance of tumor cells to tumor necrosis factor-related apoptosis-inducing ligand receptor 2-mediated apoptosis by generation of a blockade at the death domain function
Yang Li et al.
CANCER RESEARCH (2006)
Caspase-containing complexes in the regulation of cell death and inflammation
Nele Festjens et al.
BIOLOGICAL CHEMISTRY (2006)
Src kinase phosphorylates caspase-8 on Tyr380:: a novel mechanism of apoptosis suppression
Silvia Cursi et al.
EMBO JOURNAL (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Crystal structure of MC159 reveals molecular mechanism of DISC assembly and FLIP inhibition
JK Yang et al.
MOLECULAR CELL (2005)
Calmodulin binding to the Fas death domain - Regulation by Fas activation
EY Ahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis
M Chawla-Sarkar et al.
CELL DEATH AND DIFFERENTIATION (2004)
Evaluation of combination chemotherapy: Integration of nonlinear regression, curve shift, isobologram, and combination index analyses
L Zhao et al.
CLINICAL CANCER RESEARCH (2004)
Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of Fas-associated death domain and procaspase-8 to the death-inducing signaling complex
K Izeradjene et al.
CANCER RESEARCH (2004)
The curability of breast cancer and the treatment of advanced disease
V Guarneri et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Inhibitor of apoptosis proteins: Translating basic knowledge into clinical practice
AD Schimmer
CANCER RESEARCH (2004)
Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity
AD Schimmer et al.
CANCER CELL (2004)
TRAIL and apoptosis induction by TNF-family death receptors
SL Wang et al.
ONCOGENE (2003)
Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells
D Delmas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The antitumor ether lipid ET-18-OCH3 induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells
C Gajate et al.
BLOOD (2001)
Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity
K Ichikawa et al.
NATURE MEDICINE (2001)
The kiss of death: promises and failures of death receptors and ligands in cancer therapy
PT Daniel et al.
LEUKEMIA (2001)
Ceramide enables Fas to cap and kill
A Cremesti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Death domain mutagenesis of KILLER/DR5 reveals residues critical for apoptotic signaling
ER McDonald et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A
XJ Fang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
MR Sprick et al.
IMMUNITY (2000)
Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5
FC Kischkel et al.
IMMUNITY (2000)
Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand
M Jo et al.
NATURE MEDICINE (2000)
Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy
AM Chinnaiyan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
